Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy
Objective: In resource-limited countries, stavudine (d4T) is commonly used as part of the initial highly active antiretroviral therapy (HAART) regimen. Many patients who subsequently develop lipodystrophy switch from d4T to zidovudine (ZDV), a drug that can be myelotoxic. We aimed to study the spect...
Saved in:
| Main Authors: | , , , |
|---|---|
| 格式: | 雜誌 |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=42049088552&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/60476 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|